The May 15 issue of IBO contained the first-quarter Laboratory Instrument Sales Index, including estimates for Shimadzu and Oxford Instruments. Both companies have now reported their financial results for the fiscal year ending March 31. As a result, final figures for the Index have been calculated for the calendar-year first quarter. First-quarter Index revenues grew […]
In July, the Dow Jones Industrial Average enjoyed its largest one month gain in a year, climbing 7.1%. The S&P 500 and NASDAQ each gained 6.9%. Initial earnings optimism from the financial sector coupled with a modest dip in the unemployment rate from 9.7% to 9.5% sent the Dow, S&P 500 and NASDAQ each up […]
Last January, when IBO issued its industry forecast for 2010, hard evidence of a recovery from the difficult times of 2009 was almost imperceptible. First- and second-quarter 2009 financial results were dismal, and the most recent factual readings were for the third quarter of 2009, when sales were flat. So it was indeed a ”leap […]
Following up on the IBO’s April 30 article on photovoltaic energy (PV), the International Energy Agency (IEA) released its Technology Roadmap for PV earlier this month, highlighting PV’s bright future. Solar energy currently leads all clean energy technology in terms of venture capital investments, with an 88% increase from 2007 to 2008 to $5.45 billion. […]
First-quarter 2009 Life Science Index sales grew 12.3%, 9.3% on a currency-neutral basis, to $2,788.36 million. Operating profit soared 27.4% to $615.14 million, while operating margin gained 270 basis points to 22.1% of sales due to product introductions and continued cost-saving initiatives. Of the 14 Index companies, Tecan was the only company for which first-quarter […]
Washington, DC 6/10/10; Washington, DC 6/15/10—Certara, which Symyx Technologies has identified as the competitor that submitted a rival bid for the company (see IBO 5/31/10), has revoked its offer of $6.75 per share. Symyx stated that because there is now no superior proposal to Accelrys’s offer, it has terminated discussion with Certara.
Major publicly held analytical instrument and laboratory product companies experienced healthy sales growth in the first quarter of the calendar year—quite a change from a year ago and further evidence that market demand is steadily recovering. Sales to academic, government and applied markets were good, and industrial markets showed signs of life. However, pharmaceutical and […]
Volatility reached new levels this month as the European debt crisis unnerved investors. On May 6, the Dow Jones Industrial Average plummeted nearly 1,000 points intraday, and closed down 3.2%. International markets faced similar declines as France’s CAC-40 index tumbled 4.6%, Germany’s DAX fell 3.3%, Britain’s FTSE 100 dropped 2.6% and Japan’s Nikkei fell 3.1%. […]
Washington, DC 5/5/10; Washington, DC 5/21/10; Washington, DC 5/27/10—Symyx Technologies, which last month entered into a merger agreement with Accelrys (see IBO 4/15/10), announced in SEC filings that a competitor has updated its merger proposals initially made during Symyx’s negotiations with Accelrys. The latest revised offer, made on May 24, is for $6.75 per share […]
Company Announcements Anton Paar opened its 13th subsidiary in Zofingen, Switzerland, in January. In 2009, sales for Corning’s Life Sciences segment grew 12.3% to $366 million (see IBO 3/31/10) to make up 7% of company sales. The increase was due to the acquisition of Axygen (see IBO 9/30/09), but existing life science product volumes declined. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
